BioSpace News Archive

Initiative with Esports Organization Cloud9 will help gamers and fans address mental health and wellness and reduce stigma amid the COVID-19 pandemic and worsening youth mental health. [13-May-2020] OAKLAND, Calif. , May 13, 2020 /PRNewswire/ -- As part of a long-standing commitment to improve the mental health and wellness of people across the United States , Kaiser

Leading functional genomics provider The DNA Company today announced that it has acquired AI-based digital therapeutics app My Pain Sensei (MPS) for approximately $30 million USD, forming My Next Health.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 12:50 p.m. PT ( 3:50 p.m. ET ).

CytoAgents, a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases, announced today that it has been awarded a National Institutes of Health (NIH) grant to accelerate the development of its lead drug candidate, GP1681, an investigational new drug to treat severe influenza, and potentially COVID-19, by targeting hypercytokinemia,

Double Black Imaging (DBI) today announced the immediate availability of two radiology-focused medical-grade displays from LG Electronics bundled with DBI’s comprehensive calibration software package.

Autoimmune Disease Company Hires Life Science Industry Experts to Lead Company Through Next Stage into Human Clinical Studies with Novel Oral Small Molecule AX-158 [13-May-2020] CAMBRIDGE, Mass. , May 13, 2020 /PRNewswire/ -- Artax Biopharma, Inc., a biotechnology company focused on transforming autoimmune disease treatment, announces their expanded management team, b

Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has withdrawn the New Drug Applications (NDAs) for dasotraline, a novel dopamine and norepinephrine reuptake inhibitor (DNRI), for the treatment of moderate-to-severe binge eating disorder (BED) and attention deficit hyperactivity disorder (ADHD). While Sunovion considers dasotraline to be a promising, novel treatment for BED and ADHD, we believe t

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the UBS Virtual Global Healthcare Conference. The conference is being conducted with a virtual format and the presentation will take place on Wednesday, May 20, 2020 at 12:30pm Eastern Time. A live webcast of the presentatio

Ozop Surgical Corp., announces that it has successfully reduced the number of active convertible note holders from 18 down to 4 and expects that number to be down to 3 shortly.

Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy , CEO, will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19 at 12